Ginseng

PubMed ID: 27299461

IV Shenmai protected lungs and lowered inflammatory markers after ischemia‑reperfusion—supportive of organ recovery mitigation.

PubMed ID: 29892933

TJ‑100 (contains ginseng) significantly reduced postoperative weight loss and tended to lessen inflammation after esophagectomy—strong recovery signal (multi‑herb).

PubMed ID: 29747091

Daikenchuto accelerated postoperative oral intake and improved portal flow after liver transplant—benefit for postoperative recovery (contains ginseng).

PubMed ID: 31779994

Shenmai added to cardiac rehab increased early discharge 6MWD—improves early functional recovery (multi‑ingredient product).

PubMed ID: 32588153

Perioperative Daikenchuto reduced postoperative bowel symptoms (supports post‑surgical recovery of bowel function).

PubMed ID: 32172198

KRG reduced chemotherapy‑related fatigue and improved QoL domains—facilitates recovery/functional status during treatment.

PubMed ID: 32232692

Ninjin'yoeito (contains ginseng) markedly reduced oxaliplatin cumulative neuropathy and preserved chemo dosing (helps recovery/continuation of therapy).

PubMed ID: 36188425

Panax notoginseng–Ejiao suppository lowered inflammation and reduced recurrence in ulcerative proctitis (improves symptom recovery and relapse prevention).

PubMed ID: 35975564

Adjunctive Panax ginseng reduced anthracycline cardiotoxicity and preserved LVEF during chemo (supports recovery and organ protection during therapy).

PubMed ID: 37338907

Large double‑blind RCT: Panax notoginseng saponins increased proportion functionally independent after ischemic stroke (strong recovery/outcome benefit).

PubMed ID: 37218691

Panax ginseng prevented declines in physical well‑being during chemotherapy, indicating support for recovery/function in treatment period.

PubMed ID: 41022533

Antifatigue effects and lower lactic acid suggest support for recovery from exertional or chronic fatigue states.

PubMed ID: 41114550

TU-100 (contains ginseng) shortened hospital stay and modestly accelerated GI recovery after bowel resection (large trial; primary endpoint not met).

PubMed ID: 35701778

Ninjin'yoeito plus iron improved preoperative anemia correction and reduced fatigue/anxiety—supports perioperative recovery and readiness.

PubMed ID: 19216654

Ginsenosides + dexamethasone reduced post‑embolization symptoms and improved liver enzymes after TACE — supports symptomatic recovery.

PubMed ID: 25891453

Sequential Western+TCM regimen including ginseng hastened toxin elimination and shortened hospital stay in paraquat poisoning (multi‑herbal protocol) — recovery benefit though attribution to ginseng is weak.

PubMed ID: 28753932

Red ginseng improved HRQL and reduced genotoxicity in chemo patients during recovery from chemotherapy‑related damage.

PubMed ID: 23062408

Xueshuantong (Panax notoginseng components) accelerated hematoma absorption and improved neurologic scores after ICH — clear recovery‑related benefit.

PubMed ID: 17626759

Perioperative Shenqi injection (contains ginseng) improved early postoperative cellular immunity markers, supportive of surgical recovery.

PubMed ID: 21315002

Severe sepsis patients given multi‑herb including red ginseng showed lower IL‑6/TNF and higher CD4+ counts at day 7—supports acute recovery of immune function.

PubMed ID: 41683325

Panax+Astragalus saponin extract increased BCAA absorption, modestly increased muscle mass and grip strength over 4 weeks—supports nutritional recovery and muscle rebuilding.

PubMed ID: 23435143

Dai‑kenchu‑to shortened time to gastrointestinal recovery (flatus/bowel movements) after liver surgery—clinical recovery metric (multi‑ingredient product).

PubMed ID: 12528557

Shengmai‑containing therapy lowered inflammatory mediators and improved renal markers after surgery (supports recovery; multi‑herb).

PubMed ID: 15250199

Shenmai + danshen reduced inflammatory markers and improved early cardiac function after AMI (supports peri‑procedural recovery).

PubMed ID: 7842343

Ginsenosides used during cardioplegia improved postoperative cardiac function/ultrastructure (supports recovery).

PubMed ID: 8580688

Shenmai injection (contains ginseng) aided immune recovery after chemotherapy in stomach cancer patients.

PubMed ID: 12577392

Adjunctive Shengmai therapy after thrombolysis reduced ischemic area and improved EF — supports myocardial recovery (multi‑herb intervention).

PubMed ID: 12814035

Improved pulmonary function and exercise capacity in COPD implies enhanced recovery/functional status over 3 months.

PubMed ID: 12585186

Rapid clinical improvement and diaphragmatic fatigue resolution in pediatric respiratory failure with Shengmai injection — strong recovery signal in acute care context.

PubMed ID: 15074087

Panax notoginseng injection added to usual care improved intracranial pressure, GCS and 3‑month outcomes after severe head injury—direct recovery benefits.

PubMed ID: 16841676

Shenmai improved QoL, maintained weight and reduced chemo adverse reactions in lung cancer patients—supports recovery/tolerance of therapy.

PubMed ID: 16983914

Shenmai shortened ventilation and hospital stay and improved gas exchange in severe COPD—clinical recovery endpoints improved.

PubMed ID: 17455472

Faster return of flatus and improved oxidative/immune markers indicate enhanced postoperative recovery with Shenfu (multi‑component).

PubMed ID: 17343007

Panax notoginseng saponins lowered NSE and improved NIHSS/Barthel Index after cerebral hemorrhage, indicating neurologic recovery benefit.

PubMed ID: 18679601

Shengmai improved cardiac function and lowered inflammation in ACS patients, supporting recovery/functional improvement.

PubMed ID: 19317161

Multi‑herb treatment including ginseng improved infarct size and LVEF after MI and mobilized progenitor cells—strong recovery signal (multi‑component).

PubMed ID: 20082245

Chinese drug package (includes ginseng) added to chemo increased tumor response and median survival, supporting oncologic recovery/benefit (multi‑component).

PubMed ID: 19912736

Shenyi capsule plus chemotherapy lowered VEGF, reduced chemo side effects and increased 1‑year survival—supports treatment recovery/reduction in toxicity.

PubMed ID: 21094030

Panax notoginseng extract added to low‑dose aspirin improved neurological deficit scores and activities of daily living after ischemic stroke (RCT, combination therapy).

PubMed ID: 22202972

Daikenchuto reduced postoperative inflammation and accelerated bowel recovery after laparoscopic colorectal surgery (multi‑herb product including ginseng).

PubMed ID: 24895799

Daikenchuto (contains ginseng) shortened time to first flatus/bowel movement after colectomy, suggesting faster GI recovery (multi‑herb).

PubMed ID: 25632575

Acute stroke patients improved more when treated with regimens including Panax notoginseng saponins—supports enhanced recovery in multimodal therapy.

PubMed ID: 26081140

Pooled trials: ginsenoside Rd improved disability and neurologic outcomes after acute ischemic stroke—strong recovery support.

PubMed ID: 26142337

Fermented red ginseng improved fatigue and reduced chemo toxicities—adjunctive recovery support during chemotherapy.

PubMed ID: 32446979

Large multicenter RCT: Panax quinquefolius saponins (Xinyue) reduced major cardiac events after PCI (strong cardiovascular/circulatory benefit).

PubMed ID: 15143716

Panax notoginseng saponins (PNS) reduced platelet activation/aggregation and altered vasoactive markers vs aspirin in hyperviscosity patients — direct circulation support evidence.

PubMed ID: 23062408

Xueshuantong (contains Panax notoginseng) accelerated hematoma absorption and reduced inflammatory markers after intracerebral hemorrhage — supports vascular/haemostatic effects.

PubMed ID: 33370633

PNS added to aspirin increased platelet inhibition and reduced TXB2/COX‑1 oxylipids while improving gastric symptoms — clinically relevant circulatory modulation.

PubMed ID: 15706857

Panax notoginseng saponins in diabetic macroangiopathy reduced MMP‑9 (vascular remodeling marker) and improved lipid profile—direct vascular benefit.

PubMed ID: 31199705

Huoxin multi‑herb adjunct including Panax notoginseng improved IMT progression, decreased CAVI/ABI and lowered inflammatory mediators in CHD patients (clinical arterial function improvements).

PubMed ID: 23973636

12‑week RCT: 3 g/day American ginseng in people with T2D and hypertension reduced radial augmentation index (−5.3%) and systolic BP (−11.7%) vs placebo—strong clinical vascular effects.

PubMed ID: 14666758

Shenmai injection (contains ginseng) improved hemodynamics and heart function in CHF patients (human clinical hemodynamic data).

PubMed ID: 15250199

Shenmai plus danshen improved early LV function (Tei index) and reduced oxidative/inflammatory markers after AMI.

PubMed ID: 31689480

Adjunct Chinese herbal regimen including American ginseng extract reduced cardiac events after PCI—clinical cardiovascular outcome signal (multi‑herb).

PubMed ID: 27333960

Siberian ginseng acutely reduced lower‑limb edema via lymphatic endothelial activation (direct circulation/lymphatic effect).

PubMed ID: 32147072

Enriched Korean Red + American ginseng produced a small but significant reduction in central systolic blood pressure in hypertensive/diabetic patients.

PubMed ID: 2268917

Large RCT of a TCM containing ginseng reported marked improvements in angina symptoms and ECG (strong clinical circulation signal, multi‑ingredient product).

PubMed ID: 7842343

Adding ginsenosides during cardioplegia associated with better postoperative cardiac function and myocardial ultrastructure.

PubMed ID: 7950196

Small trial of a ginseng‑containing treatment reduced ECG markers and total time of asymptomatic myocardial ischemia.

PubMed ID: 7549378

Red ginseng improved hemodynamic and biochemical markers in severe heart failure (small RCT).

PubMed ID: 11475719

Panax notoginseng altered thromboxane/PGF1α and reduced urinary albumin in diabetic kidney disease — favorable vascular/thrombotic effects.

PubMed ID: 12206008

Panax notoginseng plus haemodilution improved retinal circulation time and lesion recovery in retinal vein occlusion — microcirculatory benefit.

PubMed ID: 12577392

Shengmai (multi‑herb) adjunct to thrombolysis reduced ischemic myocardial area and increased EF — improved cardiac perfusion/function reported.

PubMed ID: 12584790

Shengmai injection added to care in DCM improved EF and stroke volume and lowered vascular resistance — positive hemodynamic effects (multi‑herb context).

PubMed ID: 12764910

Shengmai injection (contains ginseng) plus usual care reduced P‑selectin, vWF and D‑dimer in chronic heart failure—markers relevant to coagulation/vascular function.

PubMed ID: 17455472

Shenfu injection lowered whole blood viscosity and related hemorheology measures postoperatively (multi‑component product).

PubMed ID: 18679601

Shengmai injection increased EF/CO/stroke volume and lowered hs‑CRP in acute coronary syndrome patients (multi‑herb adjunctive therapy).

PubMed ID: 19082800

Shengmai injection produced large improvements in NO/ET‑1/AngII and EF in CHD with diabetes (randomized, multi‑herb product).

PubMed ID: 19317161

Multi‑herb formula (includes ginseng) increased peripheral CD34+ cells and improved LVEF and infarct size after MI.

PubMed ID: 21128827

Red ginseng–enriched product lowered total and LDL cholesterol, supporting vascular/circulatory risk factor improvement.

PubMed ID: 20641058

Randomized post‑MI trial showing increased coronary flow reserve and early mobilization of angiogenic cells with red ginseng—robust cardiovascular biologic effects.

PubMed ID: 23596810

Thermal imaging study showed improved peripheral thermal distribution (proxy for circulation) though Doppler unchanged.

PubMed ID: 25284751

8‑week RCT objectively increased hand/foot skin temperatures and improved rewarming and symptoms in cold hypersensitivity (vascular effect).

PubMed ID: 24632316

Adding Panax notoginseng saponins to cell therapy significantly improved ABI, TcPO2 and walking distance in critical limb ischemia—strong vascular/flow signal.

PubMed ID: 26525022

Xue Shuan Tong reduced carotid intima‑media thickness and inflammatory markers—vascular structural improvements reported.

PubMed ID: 26081140

Pooled trials of ginsenoside Rd improved neurologic outcomes after ischemic stroke—supports cerebrovascular therapeutic effect.

PubMed ID: 27045864

Shenmai injection improved functional class and 6MWD in chronic heart failure patients—supportive of circulatory/functional benefit (short term).

PubMed ID: 26843120

Korean red ginseng lowered systolic and diastolic BP and favorably changed vascular/inflammatory metabolites in prehypertensive adults—robust BP/circulation evidence.

PubMed ID: 30650479

Shenmai (contains ginseng) improved endothelial‑dependent vasodilation, increased NO, and lowered vasoconstrictor markers—strong circulation signal (multi‑component).

PubMed ID: 29517675

Shenmai infusion produced intraoperative increases in cardiac output, stroke volume and EF in CABG patients—hemodynamic/circulatory improvement.

PubMed ID: 33171597

KRG modestly lowered cholesterol metabolites and produced a small DBP decrease in postmenopausal women (favorable vascular risk marker changes).

PubMed ID: 35975564

Small RCT: Panax ginseng adjunct during anthracycline chemo preserved LVEF and reduced cardiotoxicity incidence (direct cardioprotective/circulatory support).

PubMed ID: 35246395

After thrombolysis, Panax‑containing therapy reduced reperfusion‑inflammation markers and improved neurologic deficits (supports vascular/reperfusion protection).

PubMed ID: 37338907

Large trial: Panax notoginseng saponins increased functional independence after ischemic stroke—benefit in cerebrovascular recovery/circulation.

PubMed ID: 41111082

Xueshuantong reduced CRP/IL-6 and other markers in unstable angina, suggesting cardiovascular/circulatory benefit.

PubMed ID: 17626759

Perioperative Shenqi injection (contains ginseng) improved early postoperative T‑cell subsets (CD3+CD4+, CD4+/CD8+).

PubMed ID: 21315002

Multi‑herb recipe including red ginseng reduced IL‑6 and TNF‑α and increased CD4+ T cells in severe sepsis patients (clinical immune marker improvements).

PubMed ID: 18817894

Mixed‑plant nutraceutical containing Panax reduced leukotriene production (−43%) and basophil activation (CD63 −64.8%) in allergic subjects (large biomarker changes).

PubMed ID: 19123322

Herbal decoction including red ginseng altered cytokines (↑IL‑4, ↓IFN‑γ) and improved beta‑cell autoimmunity markers in LADA patients.

PubMed ID: 17578315

Ginseng‑saponin preparation increased clinical response in refractory ITP (immune/hematologic effect).

PubMed ID: 2100737

8‑week RCT showing increases in PMN chemotaxis, phagocytosis and intracellular killing with ginseng extract.

PubMed ID: 8580688

Shenmai (contains ginseng) improved T cell counts and NK/LAK activity after chemotherapy.

PubMed ID: 8879982

Large RCT: G115 increased vaccine antibody titres, NK activity and markedly reduced respiratory infections — strong immune support.

PubMed ID: 12577414

Ginseng polysaccharide injection raised NK/LAK activity and modestly improved remission in NPC — supports immune stimulation (in combined therapy setting).

PubMed ID: 14687309

CVT-E002 (North American ginseng extract) substantially reduced laboratory‑confirmed influenza/RSV and symptom burden in institutionalized elderly.

PubMed ID: 16247099

North American ginseng extract reduced number, severity and duration of common colds in adults over a 4‑month season.

PubMed ID: 16245914

Shenmai (ginseng-containing) plus standard therapy lowered TNF‑α and improved clinical response in aplastic anemia—immunomodulatory marker changes.

PubMed ID: 16566675

COLD-fX (North American ginseng extract) reduced incidence and duration of acute respiratory illnesses in seniors—clinical immune benefit.

PubMed ID: 17455472

Shenfu increased IgG/IgA postoperatively, suggesting some immune modulation (multi-component).

PubMed ID: 17717913

Panax notoginseng saponins reduced CRP and other inflammatory indices in RA, indicating anti‑inflammatory/immune effects.

PubMed ID: 19526756

Shengmai altered perioperative WBC, neutrophils and cytokines consistent with immune modulation (multi‑component product).

PubMed ID: 23255845

Large RCT showed a significant reduction in acute respiratory illness incidence with KRG.

PubMed ID: 22266154

In CLL patients, American ginseng increased antibody seroconversion to respiratory viruses despite no clinical ARI reduction.

PubMed ID: 25297058

14‑week RCT in older adults showed large increases in NK activity, phagocytosis and TNF‑α with a ginseng polysaccharide.

PubMed ID: 25618966

Adding ginseng polysaccharides to dendritic‑cell therapy shifted cytokines toward Th1 (immune biomarker effects; combined therapy).

PubMed ID: 27853891

Ginsenoside Rb1 reduced inflammation and oxidative stress in early CKD patients—clinically relevant immune/inflammatory benefit.

PubMed ID: 32070136

KRG lowered Th2 biomarkers (IL‑4, nasal eosinophils, IgE) and improved allergic symptoms—direct immunomodulatory effects in allergy.

PubMed ID: 36188425

Ulcerative proctitis trial showed improved Th17/Treg balance and reduced inflammatory cytokines with Panax notoginseng formulation (immune modulation).

PubMed ID: 35246395

Post‑thrombolysis formula reduced IL‑6 and TNF and other reperfusion/inflammatory markers (immuno‑inflammatory benefit with Panax-containing product).

PubMed ID: 35869725

Herbal adjunct lowered IL‑1β/IL‑1Ra gene expression in monocytes in TB patients (reduced proinflammatory gene expression; contains Shengmai/Shengmai-related herbs including Panax).

PubMed ID: 37049424

Korean red ginseng users had a sustained vaccine antibody response over 24 weeks (large cohort; nonrandomized).

PubMed ID: 41111082

Xueshuantong injection reduced inflammatory markers (CRP, IL‑6) in unstable angina, consistent with immune/inflammatory modulation.

PubMed ID: 41022533

Ginseng berry concentrate reduced subjective fatigue scores and resting lactic acid versus placebo in fatigued adults.

PubMed ID: 35701778

Ninjin'yoeito (contains ginseng) plus iron produced greater fatigue reductions than iron alone in preoperative anemia patients (direct clinical fatigue improvement).

PubMed ID: 34578969

8‑week RCT in postmenopausal women: KRG reduced fatigue severity (FSS) and increased mitochondrial DNA (plausible mechanism), direct evidence of fatigue reduction.

PubMed ID: 32172198

Large phase III RCT: KRG taken during chemotherapy reduced cancer‑related fatigue and improved fatigue-related QoL measures (direct clinical fatigue benefit).

PubMed ID: 19415341

Large randomized dose‑finding trial showed dose‑dependent trends (especially high doses) toward reduced cancer‑related fatigue and improved patient‑reported benefit.

PubMed ID: 15982990

Acute Panax ginseng reduced subjective mental fatigue during sustained mental effort.

PubMed ID: 12814035

COPD patients had increased VO2max and exercise capacity after 3 months of G115 — consistent with increased functional energy.

PubMed ID: 23613825

RDB trial in idiopathic chronic fatigue: Panax ginseng reduced mental fatigue scores and lowered oxidative‑stress markers — strong direct evidence.

PubMed ID: 28753932

Red ginseng improved fatigue subscale of HRQL in chemotherapy survivors vs placebo — supports reduced fatigue in a clinical population.

PubMed ID: 34396468

American ginseng produced acute and short‑term reductions in mental fatigue and improved self‑assurance in healthy adults.

PubMed ID: 32446979

Xinyue (Panax quinquefolius saponins) after PCI improved SF‑36 vitality scores at 12 months (patient‑reported energy/vitality improvement).

PubMed ID: 31668965

Multi‑herb formula that included ginseng produced clinically meaningful reductions in cancer‑related fatigue (ginseng may contribute but product not ginseng‑only).

PubMed ID: 27754709

Enzyme‑modified ginseng significantly reduced visual-analogue fatigue scores after 4 weeks in healthy adults.

PubMed ID: 26142337

Fermented red ginseng improved fatigue scores in lung cancer patients receiving chemotherapy—clinical fatigue benefit as adjunctive therapy.

PubMed ID: 26860800

Red ginseng increased leukocyte mtDNA copy number and anabolic hormones—biomarkers consistent with increased cellular energy.

PubMed ID: 23853057

Large phase III RCT showed statistically and clinically significant reduction in cancer‑related fatigue by 8 weeks.

PubMed ID: 23301896

3‑month RCT in MS showed significant reductions in fatigue (MFIS) and improved QoL.

PubMed ID: 40289951

Hydroponic red ginseng reduced stress and produced modest improvements on cognitive task measures in stressed adults.

PubMed ID: 34396468

RDB trial of American ginseng showed robust improvements in attention accuracy, reaction time and reduced mental fatigue — strong direct evidence.

PubMed ID: 23613825

In chronic fatigue, ginseng reduced mental fatigue and oxidative stress — may enhance mental clarity via reduced cognitive fatigue.

PubMed ID: 17993008

Traditional herbal capsule including ginseng improved memory scores in MCI patients vs baseline — supports cognitive benefit (multi‑component).

PubMed ID: 32731478

Multi‑ingredient beverage including ginseng acutely increased frontal O2 and improved some mood/fatigue measures — supports acute cognitive clarity.

PubMed ID: 25369174

Korean red ginseng modestly improved attention/hyperactivity scores and QEEG in children with ADHD symptoms.

PubMed ID: 9493479

90‑day Ginkgo/ ginseng combo produced dose‑related memory improvements in middle‑aged adults.

PubMed ID: 11140327

Large RCT of Ginkgo/ginseng combo improved composite memory quality by ~7.5%.

PubMed ID: 23950642

4‑week triple‑natural formula (includes ginseng) increased MMSE by ~2 points in MCI.

PubMed ID: 15620194

Compound ginseng product improved multiple memory test scores in elderly with mild cognitive impairment (but was multi‑herbal and single‑blind).

PubMed ID: 15982990

Single doses of Panax ginseng improved sustained-attention task performance (Serial Sevens) and reduced mental fatigue acutely.

PubMed ID: 18580589

Panax ginseng associated with short‑term cognitive improvements in Alzheimer's patients (open‑label adjunctive study).

PubMed ID: 18684311

High‑dose Korean red ginseng plus dementia meds improved ADAS and CDR scores over 12 weeks (open‑label adjunct).

PubMed ID: 20676609

Standardized American ginseng produced acute, dose‑dependent improvements in memory and working memory in healthy adults.

PubMed ID: 20737519

Acute single and 7‑day dosing produced modest improvements in calmness and some working‑memory/mental arithmetic in healthy young adults.

PubMed ID: 22213250

Standardized North American ginseng (HT1001) improved visual working memory in people with schizophrenia (4‑week RCT).

PubMed ID: 22780999

Small RCT reported cognitive improvements (MMSE/ADAS) with heat‑processed ginseng in Alzheimer's patients.

PubMed ID: 25778987

Single 200 mg American ginseng acutely improved working memory in middle-aged adults—direct human evidence for mental clarity.

PubMed ID: 30309327

Shenmai injection (contains ginseng) was associated with better short‑term postoperative cognitive scores and lower neuronal injury biomarkers after cardiac surgery.

PubMed ID: 33217050

Eight‑week RCT showed increased parahippocampal GMV and modest cognitive score improvement with KRG in healthy adults (direct brain/memory structural & functional change).

PubMed ID: 38931306

Panax ginseng sprout extract improved verbal/visual memory and MoCA scores versus placebo in adults with memory complaints.

PubMed ID: 14687309

CVT-E002 reduced influenza/RSV in institutionalized elderly—supports health protection in aging populations.

PubMed ID: 34578969

Increases in mtDNA and antioxidant status with reduced fatigue in postmenopausal women support cellular healthy‑aging mechanisms.

PubMed ID: 34684351

12‑week ginseng extract increased bone‑formation markers in postmenopausal women with osteopenia (supports musculoskeletal healthy aging).

PubMed ID: 19082800

Shengmai injection markedly improved endothelial markers and EF in CHD with diabetes; endothelial health links to healthy aging (multi‑herb).

PubMed ID: 26860800

Improvements in mitochondrial proxy, testosterone and IGF‑1 in metabolic‑syndrome men are biomarkers relevant to healthy aging.

PubMed ID: 27853891

Rb1 improved renal function and reduced oxidative stress/inflammation in early CKD—organ-level benefit relevant to aging.

PubMed ID: 32446979

Large CV outcomes trial (reduced cardiac events) with Panax quinquefolius saponins supports long‑term cardiovascular health, a component of healthy aging.

PubMed ID: 15620194

Memory improvements in elderly with MCI indicate potential healthy aging cognitive support, though study was multi‑herbal.

PubMed ID: 28753932

Red ginseng lowered genotoxicity marker (micronucleus yield) and improved multiple HRQL domains — suggests cellular‑protective/aging relevance.

PubMed ID: 23613825

Antioxidant marker improvements in chronic fatigue patients could support long‑term cellular health.

PubMed ID: 24844765

Multi‑ingredient product including ginseng improved Aging Males' Symptoms and erectile scores over 6 months (clinical aging‑related endpoints).

PubMed ID: 11140327

Ginkgo/ginseng combo produced sustained composite memory improvement in middle‑aged adults—relevant to cognitive aging.

PubMed ID: 32470863

24‑week KRG trial improved sarcopenia‑related biomarkers (follistatin, SHBG), relevant to age‑related muscle decline and healthy aging.

PubMed ID: 23950642

Memo (includes ginseng) increased MMSE in MCI patients over 4 weeks, suggesting short‑term cognitive benefit in aging.

PubMed ID: 15374200

9‑month ginseng‑containing vitamin complex improved memory index and life satisfaction in older adults.

PubMed ID: 16566675

COLD-fX reduced incidence and duration of ARI in community-dwelling seniors—clinical protective effect for older adults.

PubMed ID: 18580589

Cognitive improvements in Alzheimer's patients suggest potential support for age‑related cognitive decline (adjunctive open‑label evidence).

PubMed ID: 16959660

Larger randomized trial of ArginMax (contains ginseng) showed significant improvements in sexual desire and overall satisfaction in women — strong clinical support for sexual function (multi‑ingredient).

PubMed ID: 24844765

LER multi‑ingredient product (includes ginseng) improved Aging Males' Symptoms and IIEF‑5 erectile scores versus Kampo control (clinical improvement; multi‑herb).

PubMed ID: 8750052

Korean red ginseng produced greater partial improvements in erectile function, rigidity, girth and libido versus placebo (RCT).

PubMed ID: 12394711

Korean red ginseng significantly improved IIEF scores and penile rigidity vs placebo in men with ED — good clinical evidence for sexual vitality.

PubMed ID: 16855773

Korean red ginseng produced clinically meaningful increases in IIEF‑5 and a majority reported improved erections in men with mild‑moderate ED.

PubMed ID: 19234482

Tissue‑cultured mountain ginseng extract improved IIEF erectile function and satisfaction vs placebo in an 8‑week RCT.

PubMed ID: 20141583

Korean red ginseng modestly improved sexual arousal scores in menopausal women in a small placebo‑controlled crossover trial.

PubMed ID: 23254461

Multicenter RCT of ginseng berry extract showed modest but statistically significant improvements in erectile and sexual function scores.

PubMed ID: 26860800

Red ginseng increased total testosterone and IGF‑1 in men with metabolic syndrome—hormonal improvements relevant to sexual vitality.

PubMed ID: 25967606

Korean red ginseng improved sperm concentration, motility and morphology in infertile men in a randomized, double‑blind trial—strong sexual‑health signal.

PubMed ID: 31331583

Double‑blind RCT: Panax ginseng significantly improved female sexual function (FSFI) and menopause‑related QoL in postmenopausal women—strong direct evidence.

PubMed ID: 33730722

Four‑week Panax ginseng RCT improved women's self‑reported vaginal atrophy symptoms (subjective sexual/mucosal vitality improvement).

PubMed ID: 31082749

Ginseng extract improved self‑reported sexual function in methadone‑maintained patients in an RCT—positive short‑term evidence.

PubMed ID: 34286560

Panax ginseng‑containing supplement added to tadalafil produced greater erectile function improvement and increased platelet cGMP (direct sexual function benefit).

PubMed ID: 20940690

Multi‑ingredient supplement containing ginseng improved sperm motility and sexual satisfaction vs untreated controls — supports male sexual/reproductive outcomes (combination product).

PubMed ID: 21979301

Multi‑herbal adjunct (including ginseng) given to men with chronic prostatitis improved sperm concentration and motility — clinically meaningful reproductive improvements.

PubMed ID: 11554217

ArginMax (includes ginseng) improved multiple measures of female sexual function vs placebo in an RCT — supports sexual vitality (attributable to combination product).

PubMed ID: 8334346

Sheng Mai injection (contains ginseng) rapidly normalized thoracoabdominal motion in COPD patients (high responder rate).

PubMed ID: 8879982

G115 markedly reduced winter respiratory infections and symptoms vs placebo — clinically meaningful respiratory protection.

PubMed ID: 12585186

Shengmai injection produced rapid clinical improvement, diaphragmatic fatigue relief and better gas exchange in children with respiratory failure — strong effect in acute setting.

PubMed ID: 40819941

YHJF (includes Panax ginseng) improved clinical indices in pulmonary-derived sepsis and altered gut–lung associated microbiota (multi‑herb trial).

PubMed ID: 39681530

Ginseng-containing phytopreparation improved some hypoxia-related respiratory parameters and oxygen saturation in pneumonia patients.

PubMed ID: 36640005

Shengmai Yin modestly improved chest‑distress in COVID‑19 convalescent patients (direct respiratory symptom relief).

PubMed ID: 32070136

KRG improved allergic rhinorrhea, nasal/eye itching and reduced nasal eosinophils/IL‑4 in allergic rhinitis—direct symptomatic respiratory benefit in upper airway allergy.

PubMed ID: 27299461

IV Shenmai preserved pulmonary gas exchange and lowered inflammatory markers after limb ischemia‑reperfusion—clinical respiratory-protective signal.

PubMed ID: 23255845

KRG reduced incidence of acute respiratory illness (clinical respiratory benefit).

PubMed ID: 19685757

Shenmai injection attenuated post‑CPB rises in ET‑1 and improved P(A‑a)DO2/RI, indicating respiratory benefit (multi‑component).

PubMed ID: 19673331

Perioperative Shenmai infusion (contains ginseng) reduced lung injury markers and improved oxygenation after CPB (small RCT, multi‑component).

PubMed ID: 12814035

Randomized trial in moderate–severe COPD showed large, consistent improvements in FEV1, VO2max and exercise capacity — strong respiratory benefit.

PubMed ID: 18817894

Mixed‑plant product containing Panax reduced leukotriene production and basophil activation (CD63) in allergic subjects—biomarkers relevant to respiratory allergy/inflammation.

PubMed ID: 16983914

Shenmai injection added to NPPV in severe COPD shortened ventilation and hospitalization times and improved arterial blood gases and dyspnea scores.

PubMed ID: 16566675

COLD-fX reduced ARI incidence and shortened symptom duration in seniors—clinical respiratory benefit.

PubMed ID: 16247099

North American ginseng extract reduced common cold incidence/severity/duration—supports respiratory symptom reduction.

PubMed ID: 26141466

Large RCT: DKT modestly sped bowel recovery after gastrectomy, especially in adherent patients—clinical digestive support.

PubMed ID: 24895799

Daikenchuto (includes ginseng) shortened time to flatus/bowel movement after colectomy (clinically meaningful but multi‑herb).

PubMed ID: 22202972

Daikenchuto (multi‑herb including ginseng) shortened time to first flatus and lowered postoperative CRP after colorectal surgery.

PubMed ID: 17455472

Shenfu injection shortened time to first flatus after abdominal surgery, a direct digestive/recovery benefit.

PubMed ID: 20378829

TU‑100 (contains ginseng) accelerated ascending colon emptying in healthy humans at higher dose.

PubMed ID: 23435143

Dai‑kenchu‑to (Kampo mix that can include ginseng) shortened time to first flatus/bowel movement and reduced postoperative inflammation after liver resection.

PubMed ID: 33370633

PNS + aspirin reduced aspirin‑related gastric symptoms (improved SODA dyspepsia scores) — direct improvement in digestive comfort.

PubMed ID: 41114550

TU-100 (contains ginseng) modestly accelerated GI recovery, reduced LOS and nausea in post‑resection patients.

PubMed ID: 29747091

Daikenchuto after liver transplant accelerated oral/enteral intake and increased portal flow (secondary digestive/recovery signals).

PubMed ID: 25564322

Daikenchuto (contains ginseng) after gastrectomy increased stool frequency/form and reduced abdominal gas—clear digestive benefit (multi-herb product).

PubMed ID: 36188425

Panax notoginseng–Ejiao suppository improved symptoms and reduced recurrence in ulcerative proctitis (direct GI symptom/inflammation improvement).

PubMed ID: 32588153

Perioperative Daikenchuto (multi‑herb including ginseng) reduced bowel movements and incomplete evacuation after colorectal surgery (direct digestive symptom benefit).

PubMed ID: 31823650

Daikenchuto (contains ginseng) produced large, significant improvements in constipation scores and reduced intestinal gas after stroke.

PubMed ID: 15889524

Shenmai (contains ginseng) increased SOD activity and decreased MDA in elderly coronary heart disease patients—direct antioxidant marker changes.

PubMed ID: 15250199

Shenmai (contains ginseng) preserved SOD and lowered MDA after PCI (human clinical data).

PubMed ID: 27853891

Extended Rb1 treatment reduced oxidative stress markers in early CKD patients—clinical antioxidant signal.

PubMed ID: 30650479

Shenmai (contains ginseng) increased SOD and improved NO/oxidative marker profile—supports antioxidant action (multi‑component product).

PubMed ID: 18568324

Shenfu regimen decreased MDA and increased SOD in small perioperative group (multi‑component injection).

PubMed ID: 21699953

Placebo-controlled trial in healthy volunteers showing decreased ROS/MDA and increased glutathione and GSH‑Rd with 2 g/day Panax ginseng.

PubMed ID: 22805313

Large RCT showed increased SOD/GPx/catalase and reduced oxidized LDL and DNA oxidative damage.

PubMed ID: 24814037

12‑week RCT increased SOD activity in postmenopausal women (biomarker signal).

PubMed ID: 34578969

Twelve-week RCT showed increased total antioxidant status (TAS) and mtDNA in KRG users (direct antioxidant biomarker change).

PubMed ID: 35246395

Post‑thrombolysis trial reported increased SOD and decreased MDA (antioxidant/reperfusion marker improvements) with a Panax-containing formula.

PubMed ID: 17455472

Shenfu injection raised SOD and lowered MDA after surgery, indicating antioxidant effects (multi-component product).

PubMed ID: 23613825

RDB trial showed decreased ROS and MDA and increased GSH activity with Panax ginseng — direct antioxidant biomarker improvements.

PubMed ID: 28753932

Red ginseng reduced micronucleus yield (less genotoxicity) — consistent with antioxidant/protective effects.

PubMed ID: 15982990

Acute Panax ginseng improved a sustained-attention subtraction task and reduced mental fatigue.

PubMed ID: 32847461

Omega‑3 plus Korean red ginseng improved ADHD symptom scores and attention measures in children (combination product).

PubMed ID: 25369174

Korean red ginseng produced statistically significant improvements in inattention and EEG TBR in children with ADHD symptoms.

PubMed ID: 32731478

Beverage with ginseng increased frontal oxygenation and improved some alertness/mental fatigue measures — supports acute focus.

PubMed ID: 17993008

Herbal capsule including ginseng improved memory and related cognitive measures in older adults — relevant to attentional performance.

PubMed ID: 34396468

American ginseng improved sustained and executive attention outcomes in an RCT — clear support for improved focus.

PubMed ID: 22780999

Cognitive test improvements in Alzheimer's suggest benefits for attention/focus in that population.

PubMed ID: 25778987

Working-memory improvements in a crossover study imply improved short-term focus after American ginseng.

PubMed ID: 33217050

KRG produced modest composite cognitive improvements (attention/executive domains included), supporting focus benefits.

PubMed ID: 38931306

Cognitive trial showed memory and global cognition gains which support improved attentional function.

PubMed ID: 22213250

HT1001 improved visual working memory in schizophrenia, indicating meaningful cognitive/attention benefit in that population.

PubMed ID: 20676609

Acute standardized American ginseng reliably improved working memory speed and attention measures in healthy adults.

PubMed ID: 11140327

Ginkgo/ginseng combo improved working memory and contributed to composite memory gains (attention component).

PubMed ID: 21128827

Red ginseng–enriched product lowered fasting blood glucose in subjects with impaired fasting glucose over 8 weeks (small RCT).

PubMed ID: 19123322

In LADA patients a multi‑herb decoction including red ginseng improved beta‑cell function and reduced insulin dose requirements (human clinical signal).

PubMed ID: 23675990

Two‑week fermented red ginseng in postmenopausal women modestly reduced HbA1c, insulin and HOMA‑IR (statistically significant but small effects).

PubMed ID: 18198636

Panax quinquefolius saponin improved HOMA‑beta (beta‑cell function) and was associated with glucose changes in CHD patients with abnormal glucose (adjunct therapy).

PubMed ID: 19960983

Renshen Jianxin Capsule (ginseng‑based) improved insulin sensitivity measures over 20 weeks, comparable to metformin in CHD patients with IGT.

PubMed ID: 22499718

Short‑term PNG lowered early postprandial glucose and 0–90 min AUC in healthy men (acute glycemic effect).

PubMed ID: 25015735

4‑week RCT in impaired glucose regulation showed significant 2‑h postprandial glucose and AUC reductions and increased insulin.

PubMed ID: 24456363

12‑week RCT in IFG/IGT/new T2DM lowered early post‑load glucose (30 min) with trends for AUC reduction.

PubMed ID: 37454261

Shenlian formula (Huanglian + Renshen) produced significant reductions in postprandial glucose, HOMA‑IR and CRP over 12 weeks (direct glycemic/improvement evidence).

PubMed ID: 39004031

Ginseng-berry saponins reduced 2‑h postprandial glucose and improved HOMA-IR in prediabetes (well-powered RCT crossover).

PubMed ID: 39969290

Korean red ginseng extract modestly improved fasting/postprandial glucose and insulin-resistance markers in prediabetic adults.

PubMed ID: 31779994

Shenmai (includes ginseng) led to a clinically meaningful ~43 m greater 6‑minute walk distance at discharge—strong signal for short‑term stamina.

PubMed ID: 27045864

Shenmai injection improved 6MWD and NYHA class in heart‑failure patients over one week—improved short‑term stamina/function as adjunct.

PubMed ID: 12814035

G115 produced large VO2max and exercise capacity gains in COPD patients — strong endurance benefit in disease population.

PubMed ID: 1301847

Ginseng‑containing formula increased exercise time and workload (~30% increases) in angina patients.

PubMed ID: 37338907

Large ischemic stroke trial with Panax notoginseng saponins improved functional independence at 3 months, plausibly reflecting increased activity/endurance capacity.

PubMed ID: 38512715

Multi‑ingredient supplement including Panax improved positive affect and delayed recall vs placebo after 28 days (clinical mood outcome).

PubMed ID: 28753932

Red ginseng improved emotional function and anxiety subscales of HRQL in chemo patients — supports mood enhancement in a clinical context.

PubMed ID: 15374200

9‑month ginseng‑containing vitamin complex improved self‑reported life satisfaction (mood/quality‑of‑life) in older adults.

PubMed ID: 34396468

American ginseng improved subjective self‑assurance and reduced mental fatigue in RCT — indicates modest mood/affect benefit.

PubMed ID: 16882101

Sun ginseng improved psychological QoL and GHQ‑12 scores in cancer patients indicating better mental health/mood.

PubMed ID: 35701778

Ninjin'yoeito + iron reduced anxiety VAS more than iron alone (direct mood/anxiety improvement).

PubMed ID: 37218691

Prevention of decline in emotional well‑being during chemotherapy supports mood benefit (small RCT).

PubMed ID: 40289951

Hydroponic red ginseng reduced negative affect (PANAS‑N) and perceived stress in a randomized trial.

PubMed ID: 26860800

Red ginseng lowered serum cortisol in metabolic‑syndrome men—objective marker of reduced physiological stress.

PubMed ID: 28753932

Red ginseng improved emotional function and anxiety subscales of HRQL in chemo patients — supports stress/anxiety symptom relief.

PubMed ID: 40289951

Hydroponic red ginseng significantly reduced perceived stress (PSS) and negative affect versus placebo in moderately stressed adults.

PubMed ID: 37218691

Improvement/preservation of emotional well‑being during chemotherapy indicates stress-related QoL benefit (small RCT).

PubMed ID: 35701778

NYT (contains ginseng) plus iron reduced anxiety (VAS‑A) more than iron alone in preop patients (direct stress/anxiety relief).

PubMed ID: 28753932

Red ginseng improved the sleep subscale of HRQL in chemotherapy survivors vs placebo — evidence for improved sleep quality in this population.

PubMed ID: 17454163

3‑month multi‑herb formula including American ginseng markedly reduced hot flushes/night sweats and improved sleep quality in menopausal women (randomized double‑blind).

PubMed ID: 20041778

24‑week RCT of a red ginseng‑containing herbal mixture reduced facial wrinkles and increased type I procollagen expression vs placebo (objective skin outcomes; multi‑herb).

PubMed ID: 37454261

Shenlian formula decreased BMI over 12 weeks in T2DM patients (direct modest weight/BMI effect).